The Effect of Clofibrate and Phototherapy on Prolonged Jaundice due to Breast Milk in Full-Term Neonates.

Clofibrate Prolonged hyperbilirubinemia jaundice neonatal

Journal

Clinical medicine insights. Pediatrics
ISSN: 1179-5565
Titre abrégé: Clin Med Insights Pediatr
Pays: United States
ID NLM: 101595023

Informations de publication

Date de publication:
2023
Historique:
received: 12 03 2022
accepted: 05 05 2023
pubmed: 13 7 2023
medline: 13 7 2023
entrez: 13 7 2023
Statut: epublish

Résumé

Jaundice is one of the most common problems during infancy. It is believed that breast milk jaundice is one of the reasons for the persistence of jaundice after 14 days of prolonged jaundice. This study evaluates the effect of Clofibrate and phototherapy on prolonged jaundice originating from breast milk in term and healthy neonates. This double-blind clinical trial study was performed on 100 randomly divided neonates in the neonatal ward of Besat Hospital. In addition to phototherapy, the case group received a single dose of edible Clofibrate (50 mg/kg) dissolved in 2 CCs of distilled water. The control group received the same amount of distilled water as the phototherapy group. After treatment, bilirubin change rate, duration of hospitalization, and any association with gender, gestational age, hemoglobin, blood type, and Rh of neonates were determined and compared throughout the 2 groups. Data analysis showed that the bilirubin reduction rate was statistically significantly higher in the case group than in the control group ( This study's results demonstrated that Clofibrate effectively decreased bilirubin levels and shortened the duration of phototherapy and hospitalization in infants with probable breast milk jaundice. IRCT2012092910933N1.

Identifiants

pubmed: 37441564
doi: 10.1177/11795565231177987
pii: 10.1177_11795565231177987
pmc: PMC10333635
doi:

Types de publication

Journal Article

Langues

eng

Pagination

11795565231177987

Informations de copyright

© The Author(s) 2023.

Déclaration de conflit d'intérêts

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Fatemeh Eghbalian (F)

Department of Pediatrics, Hamadan University of Medical Sciences, Hamadan, Iran.

Roya Raeisi (R)

Department of Pediatrics, Hamadan University of Medical Sciences, Hamadan, Iran.

Javad Faradmal (J)

Department of Biostatistics, School of Health, Modeling of Non communicable Diseases Research Center, Health Sciences and Technology Research Institute, Hamadan University of Medical Science, Hamadan, Iran.

Amin Asgharzadeh (A)

Department of Pediatrics, Hamadan University of Medical Sciences, Hamadan, Iran.

Classifications MeSH